Life science News and Research

RSS

Sir Richard Doll awarded prestigious Shaw Prize for his contribution to modern cancer epidemiology

Professor Sir Richard Doll has been awarded the prestigious Shaw Prize in Life Science and Medicine for his contribution to modern cancer epidemiology.

23 Jun 2004

New software helps understanding of protein-protein docking

These algorithms enable more efficient life science research by helping scientists to understand the action of therapeutically interesting proteins by predicting the manner in which two proteins interact at the atomic level.

15 Jun 2004

New portable device for detection of biological agents

The M-SERIES product line has multiple applications and currently serves the biodefense, life science research and food testing markets.

2 Jun 2004

Nanobodies herald a new era in cancer therapy

Cancer, along with heart and vascular disease, is the major cause of death in the Western world. The first generation of anti-cancer drugs has already saved many lives, but because these medicines are non-specific they also often have severe side effects.

12 May 2004

Europe-wide network fighting heart disease

Academic expertise at the University of Birmingham's Medical School is contributing to a Europe-wide network fighting heart disease. The European Vascular Genomics Network (EVGN) is the first European Funded network of excellence in the field of cardiovascular disease.

10 May 2004

Clemson launches DNA learning center

Clemson University has teamed up with the nation's leading genetics learning center to help S.C. students and teachers understand the far-reaching impact genetics will have on the future.

22 Apr 2004

World's largest drug-like library comprising 100 million diverse compounds synthesised in a single test tube

Nuevolution A/S, a privately held drug discovery company today announced that it has generated what it believes to be the world's largest drug-like library comprising 100 million diverse compounds synthesised in a single test tube.

19 Apr 2004

A simple urine sample could soon be used to predict the complex toxic effects of new drugs

BlueGnome has pioneered the use of statistical signal modelling in the analysis of high throughput experimental data. Its first product BlueFuse for Microarrays uses statistical modelling techniques to eliminate Œnoise‚ generated in microarray experiments, enabling researchers to automatically identify the presence or absence of genes and proteins with a higher level of confidence than is currently possible.

5 Apr 2004

Joint Research Collaboration to Predict 3-D Protein Structures and Support Drug Discovery

IBM today announced that the University at Buffalo (UB) Center of Excellence in Bioinformatics, The State University of New York, will use IBM technologies and research expertise to study the structure and behavior of human proteins. The outcome of this research could lead to more targeted drugs to treat diseases such as cancer, Alzheimer's, AIDS and multiple sclerosis.

25 Mar 2004